PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.3950
0.00 (0.00%)
Nov 9, 2026, 4:00 PM EST
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 77.81 million as of November 9, 2026. It is the 29,202nd most valuable company in the world and the 792nd biggest in Canada. Its market cap has decreased by 6.78% in one year.
Market Cap
77.81M
Enterprise Value
58.61M
Revenue
27.41M
Global Rank
Country Rank
#792 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 77.81M, an increase of 3,141.98%. That is a compound annual growth rate of 132.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 77.81M | 2.44% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 8.03B |
| Curaleaf Holdings | 3.41B |
| Extendicare | 2.73B |
| Sienna Senior Living | 2.31B |
| Charlotte's Web Holdings | 84.10M |
| Decibel Cannabis Company | 76.17M |
| Leef Brands | 74.86M |
| Helix BioPharma | 68.74M |